Who makes Dilaudid (hydromorphone) and who owns the brand? Dilaudid is a brand name for hydromorphone, an opioid pain medicine…. https://www.Drugchatter.com/chat/53035/who-owns-dilaudid-company/

What is the Chinese (CN) name for Ozempix? The provided information doesnt include any details about a product named… https://www.Drugchatter.com/chat/36985/ozempix-chinese-name/

Which Chinese pharmaceutical companies are investing in AI? A number of Chinese drugmakers have been putting money into… https://www.Drugchatter.com/chat/50765/chinese-pharmsutical-company-investing-in-ai/

Is Gleevec (imatinib) among the most expensive drugs? Gleevec (imatinib) is widely known as an expensive cancer medicine,… https://www.Drugchatter.com/chat/31710/is-gleevec-the-most-expensive-drug/

Branded Generics vs. Commodity Generics: How Brand Trust Wins Market Share
In generic drugs, the conversation is often framed as a race to the lowest price. But in the real worldwhere formularies change, patients switch, and payers scrutinize utilizati…

Pharma has a timing problemand its getting more expensive.
In a world where launches are won (or lost) in the months before the first prescription is written, filing later is no longer a strategy. Its a liability. The latest playbook emerging across th…

Dont Get Blindsided: The Critical Drug Patent Mistakes to Avoid in MA Due Diligence
In Massachusetts, a single overlooked patent detail can turn a routine diligence sprint into a costly timelineand a valuation problem you cant easily explain to investo…

Post-Approval Patents: The Hidden LOE Risk Map Pharma Teams Miss
In the race from FDA approval to durable revenue, most teams obsess over the obvious: Orange Book listings, primary patents, and the litigation calendar. But the real threat to launch tim…

Post-Approval Patents: The Hidden Loe Risk Map Pharma Cant Afford to Ignore
Most teams think the patent story ends at approval.
They shouldnt.
In the post-approval world, the real risk often hides in plain sight: patents that are filed, asserted, or st…

Beyond 20 Years: What Actually Determines a Drugs Market Exclusivity
Most people think drug exclusivity is a simple countdown: You get 20 years, then generics arrive. In reality, the clock is messierand the outcome is often decided by a handful of lega…